Mednax Inc (MD) 72.46 $MD Mednax Shares Up 34.2% Since

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mednax Inc (MD) 72.46 $MD

Mednax Shares Up 34.2% Since SmarTrend's Buy Recommendation (MD)
Comtex SmarTrend(R) - Fri Mar 20, 11:23AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 5 months, Mednax has returned 34.25% as of today's recent price of $72.99.
MD: 72.46 (+0.32)

Mednax initiates second $200M accelerated share repurchase program
Seeking Alpha - at Seeking Alpha - Tue Mar 17, 3:19PM CDT

MD: 72.46 (+0.32)

Mednax Has Returned 35.3% Since SmarTrend Recommendation (MD)
Comtex SmarTrend(R) - Fri Mar 13, 9:50AM CDT
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 5 months, Mednax has returned 35.31% as of today's recent price of $73.57.
MD: 72.46 (+0.32)

MEDNAX Commences Second $200 Million Accelerated Share Repurchase Program
Business Wire - Thu Mar 12, 6:00AM CDT
MEDNAX, Inc. (NYSE: MD), the national medical group specializing in neonatal, anesthesia, maternal-fetal, pediatric cardiology, and other pediatric physician services, today announced the commencement of a second $200 million accelerated share repurchase (ASR) program with JPMorgan Chase Bank, N.A. This program follows the Company's first ASR that commenced in December, 2014.
MD: 72.46 (+0.32)

Insider Trading Alert - OMC, MD And EDE Traded By Insiders
at The Street - Mon Mar 02, 11:45AM CST
Stocks with insider trader activity include OMC, MD and EDE
OMC: 78.31 (+0.08), EDE: 25.54 (+0.55), MD: 72.46 (+0.32)

Seeking Daruma: Zen And The Art Of Small Cap Investing
Matthew Finston - at Seeking Alpha - Fri Feb 20, 10:07AM CST

CSGP: 196.78 (-0.88), PRGO: 172.87 (+2.50), XYL: 35.99 (+0.45), FRAN: 16.13 (+0.08), TTI: 5.91 (+0.27), LL: 28.51 (-0.84), HLS: 45.30 (+0.35), GOOG: 560.36 (+2.37), PVH: 102.44 (+0.81), STNG: 9.05 (+0.04), ROG: 83.28 (+0.29), TRAK: 38.84 (-0.25), WCG: 93.72 (+0.61), MD: 72.46 (+0.32), SPN: 21.19 (+0.82), MU: 28.68 (+0.63), WLL: 39.03 (-1.04), EFII: 42.06 (+0.77), DGI: 34.75 (+0.04), PBI: 23.96 (+0.71), UHS: 118.76 (+0.03), CDNS: 18.66 (+0.06), BECN: 30.43 (+1.08), NXPI: 108.03 (+2.71), LYV: 25.50 (-0.01), PODD: 33.95 (-0.43), WEX: 107.22 (+3.31), ASGN: 38.80 (+0.13), AIG: 55.94 (+0.29), CTCT: 38.97 (+0.69), OXM: 58.38 (-0.08), STKL: 11.01 (+0.50), AWI: 57.53 (+1.24), MFRM: 67.72 (+3.69), BDC: 92.13 (+1.46), QEP: 20.78 (+0.38), BC: 51.25 (+0.15), SHLM: 44.79 (+0.45), MNRO: 66.92 (+0.74), VRA: 15.84 (-0.01), GOOGL: 564.95 (+1.28), AVY: 53.49 (+0.49), OC: 42.43 (+2.71), WAB: 96.57 (+1.39), CRZO: 47.86 (+1.37), NATI: 32.83 (-0.02), DBD: 34.59 (+0.39), RATE: 11.73 (+0.13), ALGN: 57.18 (-1.14), FBHS: 46.16 (+1.08), WDC: 100.44 (+1.14), DIN: 106.25 (+0.23), ACXM: 19.59 (unch), TCBI: 49.54 (+0.91), PLL: 103.61 (-0.47), FUL: 43.81 (+0.49), PCRX: 97.64 (-0.08), BABA: 85.20 (-0.54)

Sector Rankings Stay Neutral With Few Bullish Catalysts On Horizon
Scott Martindale - at Seeking Alpha - Wed Feb 18, 12:49AM CST
Stocks are hitting new highs across the board, even though earnings reports have been somewhat disappointing. Actually, to be more precise, Q4 results have been pretty good, but it is forward guidance that has been cautious and/or cloudy as sales...
IYK: 105.91 (+1.16), ACHC: 72.77 (+1.17), IYJ: 109.99 (+0.71), BX: 38.69 (unch), IYH: 159.39 (+0.86), IYM: 82.53 (+0.67), IYC: 147.34 (+1.37), AMP: 136.17 (+2.83), IYF: 91.39 (+1.22), IYE: 43.63 (+0.61), KBWI: 69.39 (-0.26), IHF: 134.41 (+0.34), IYZ: 31.26 (+0.37), SPY: 210.41 (+0.91), MRVL: 15.72 (-0.08), IDU: 113.91 (+1.13), FONE: 40.83 (+0.46), MD: 72.46 (+0.32), AVGO: 133.29 (+1.25), IYW: 107.91 (+0.62)

Mednax Up 30.9% Since SmarTrend Uptrend Call (MD)
Comtex SmarTrend(R) - Thu Feb 12, 10:02AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 4 months, Mednax has returned 30.88% as of today's recent price of $71.16.
MD: 72.46 (+0.32)

Mednax Up 26.6% Since SmarTrend Uptrend Call (MD)
Comtex SmarTrend(R) - Thu Feb 05, 9:15AM CST
SmarTrend identified an Uptrend for Mednax (NYSE:MD) on October 21st, 2014 at $54.37. In approximately 4 months, Mednax has returned 26.60% as of today's recent price of $68.83.
MD: 72.46 (+0.32)

'Mad Money' Lightning Round: Ambarella Is Like Putting a Gun to Your Head
at The Street - Thu Feb 05, 5:00AM CST
Cramer says take the money and run on NPS Pharmaceuticals, stay away from VMware and he missed the boat on OvaScience.
AMBA: 72.39 (+3.14), BX: 38.69 (unch), VMW: 82.82 (+1.05), OVAS: 46.97 (+1.98), NBR: 13.15 (+0.36), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), HAIN: 64.44 (+0.88), SSYS: 58.89 (+0.51), NPSP: 45.97 (+0.01), PPC: 26.84 (-0.10), FLT: 152.16 (+0.65), MD: 72.46 (+0.32)

Blackstone Is An Excellent Holding - Cramer's Lightning Round (2/4/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Thu Feb 05, 4:21AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 4. Bullish Calls: Alaska Air (NYSE: ALK ): " I like Alaska Air and I like Southwest Airlines (NYSE: LUV )." OvaScience (NASDAQ:...
AMBA: 72.39 (+3.14), BX: 38.69 (unch), OVAS: 46.97 (+1.98), VMW: 82.82 (+1.05), NBR: 13.15 (+0.36), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), SSYS: 58.89 (+0.51), PPC: 26.84 (-0.10), NPSP: 45.97 (+0.01), FLT: 152.16 (+0.65), MD: 72.46 (+0.32)

Jim Cramer's 'Mad Money' Recap: Zombie Stocks That Will Rise From the Dead
at The Street - Wed Feb 04, 7:26PM CST
Many of the stocks hit hard Wednesday will rise again soon enough, Cramer says.
KMI: 42.12 (+0.59), MMM: 166.49 (+0.83), BX: 38.69 (unch), VMW: 82.82 (+1.05), OVAS: 46.97 (+1.98), NKE: 101.98 (+3.66), FRPT: 18.31 (-0.16), NBR: 13.15 (+0.36), WYNN: 129.98 (-0.13), RL: 133.18 (+0.54), UPS: 100.25 (+0.34), SLB: 82.37 (+1.36), LUV: 46.36 (+0.01), WHR: 197.95 (+3.81), JNJ: 102.40 (+0.71), BC: 51.25 (+0.15), CMG: 686.65 (+5.98), SSYS: 58.89 (+0.51), PPC: 26.84 (-0.10), NPSP: 45.97 (+0.01), DG: 75.78 (+0.87), CAT: 81.19 (+1.10), MD: 72.46 (+0.32), AAPL: 125.90 (-1.60), REGN: 488.87 (+2.85), WFM: 53.97 (+0.35), AMBA: 72.39 (+3.14), NSC: 110.43 (+0.12), MCK: 229.94 (+4.19), NUE: 47.14 (+1.04), HAL: 42.82 (+1.27), DIS: 108.43 (+1.06), COP: 63.84 (+1.08), BMY: 67.76 (-0.56), ALK: 68.68 (+0.33), HPQ: 33.28 (+0.44), CELG: 128.50 (+3.17), HAIN: 64.44 (+0.88), TTWO: 25.68 (-0.04), GILD: 102.29 (+0.85), MCD: 97.05 (+1.07), FLT: 152.16 (+0.65), PG: 84.74 (+1.36)

Mednax: Investment Thesis Intact, Discount Is Gone
Investing Doc - at Seeking Alpha - Tue Feb 03, 7:32AM CST

MD: 72.46 (+0.32)

Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 64.02 (-0.19), AFAM: 38.81 (-0.25), SCAI: 35.04 (+0.02), HLS: 45.30 (+0.35), MD: 72.46 (+0.32)

Insider Trading Alert - MD, OKSB And UPI Traded By Insiders
at The Street - Mon Feb 02, 9:56AM CST
Stocks with insider trader activity include MD, OKSB and UPI
OKSB: 17.17 (+0.63), UPI: 1.10 (-0.03), MD: 72.46 (+0.32)

MEDNAX Announces Acquisition of Anesthesiology Practice in Michigan
Business Wire - Fri Jan 30, 6:00AM CST
MEDNAX, Inc. (NYSE: MD), today announced the acquisition of MEMAC Associates, P.C., a private physician group practice based in Warren, Mich., and its related entity, Synergy Anesthesia, PLLC. At closing, 10 anesthesiologists, as well as 18 part-time anesthetists, became part of MEDNAX's American Anesthesiology division, and will serve as one integrated practice.
MD: 72.46 (+0.32)

Team Health Holdings: A Well-Run Company With Strong Growth Prospects
Real Estater - at Seeking Alpha - Fri Jan 30, 12:24AM CST

AMSG: 64.02 (-0.19), EVHC: 38.60 (+0.42), TMH: 59.25 (+0.66), MD: 72.46 (+0.32)

SmarTrend Watching for Potential Pullback in Shares of Mednax After 6.68% Gain
Comtex SmarTrend(R) - Thu Jan 29, 4:39PM CST
Mednax (NYSE:MD) traded in a range yesterday that spanned from a low of $64.80 to a high of $69.20. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $65.49 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MD: 72.46 (+0.32)

MEDNAX (MD) Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Jan 29, 2:30PM CST

MD: 72.46 (+0.32)

Barbarian At The Gate: Mednax (MD)
at The Street - Thu Jan 29, 9:44AM CST
Trade-Ideas LLC identified Mednax (MD) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
MD: 72.46 (+0.32)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 6

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 8

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 8

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 14

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 7

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading

Top 5 Most Recently Viewed Articles

Viper Energy Partners LP Reaches New Heights with Stock Surge

Updated Category News Views 119

Stock Performance Overview In a significant show of market confidence, Viper Energy Partners LP (NASDAQ: VNOM) has reached a remarkable stock price milestone, hitting $56.08 at its peak. This achievement underlines the company's strong performance and the optimism surrounding its future prospects. Over the last year, the stock price of Viper Energy has experienced a...

Continue Reading
A2 Biotherapeutics Showcases Innovative Cell Therapy Trials

Updated Category News Views 194

A2 Biotherapeutics Showcases Innovative Cell Therapy Trials A2 Biotherapeutics, Inc. (A2 Bio) has made a significant announcement about its upcoming presentations at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC). The company is set to reveal six abstracts, showcasing their dedication to advancing cancer treatment methodologies. This event is a...

Continue Reading
Spectral AI Announces Significant Advances Before FDA Review

Updated Category News Views 202

Spectral AI's Financial Strengthening Journey Recently, the innovative company, Spectral AI (NASDAQ: MDAI), which is at the forefront of AI-driven solutions in healthcare, has achieved a significant milestone by fulfilling its remaining obligations under a debt facility with Yorkville Advisors. The company's proactive financial strategies have opened doors to additional...

Continue Reading
Tillamook Celebrates Cheddar Day with Extraordinary Cheese Giveaway

Updated Category News Views 119

Celebrating National Cheddar Day with Tillamook Tillamook County Creamery Association (TCCA) has a delicious way of celebrating National Cheddar Day this year. As a co-op renowned for its extraordinary dairy products, Tillamook is inviting cheese lovers to participate in an exciting giveaway that promises to delight the senses. Picture this: 1909 pounds of cheese, just...

Continue Reading
Soligenix, Inc. Prepares for ThinkEquity Conference 2024

Updated Category News Views 65

Soligenix, Inc. Prepares for ThinkEquity Conference 2024 Soligenix, Inc. (NASDAQ: SNGX), a pioneering biopharmaceutical company, is set to participate in the much-anticipated ThinkEquity Conference. This event is scheduled to take place at the renowned Mandarin Oriental Hotel in New York. The conference serves as an exceptional platform for companies to showcase...

Continue Reading